Future perspectives for PDE5 inhibitors bridging the gap between cardiovascular health and psychological status
Abstract The serendipitous discovery that inhibiting type 5 phosphodiesterase (PDE5) using sildenafil, a potent PDE5 inhibitor (PDE5i) initially developed for cardioprotection, introduced the possibility of orally managing erectile dysfunction (ED) led to an increase in research data, which are curr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Basic and Clinical Andrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12610-024-00245-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|